Electronic informed consent (eConsent) solutions have been introduced in recent years, representing a major advancement in improving information delivery to study par...

Adrenocortical carcinoma (ACC) is a rare cancer with an estimated incidence of 1 to 2 patients per million people annually. About 50%–70% of adrenal cancers are funct...

Pediatric legislation was introduced based on the American Academy of Pediatrics (AAP) concerns that children did not participate sufficiently in therapeutic progress...

Henry J. Riordan, Ph.D., Executive Vice President of Medical and Scientific Affairs and Global Lead for Neuroscience at Worldwide Clinical Trials, shares his views on...

A great number of willing patients, highly experienced researchers and EMA-compliant legislation make the CEE region an attractive research site destination. The data...

China has a large and vibrant ecosystem of patient advocacy groups and digital health networks that provides clinical trial sponsors with opportunities to engage and ...

One area in the clinical trial process that has been identified for improvement is risk-based planning and management. Monitoring and managing risk has always been a ...

CDSIC is meant to enable you to collect, store and transfer clinical data in a way that makes them easily usable on a large scale in an unambiguous way. Collecting da...

Monoclonal antibodies (mAb) are among the most promising biologic drugs currently on the market for treatment of life-threatening diseases. The selectivity and specif...

Pharmacovigilance will always be about protecting patients. The discipline is rapidly evolving into something greater than regulatory compliance; increasingly, pharma...